ONCO Round Table on gastrointestinal cancer
{{ getTitle(live) }}
{{ toDate(live.liveStartDate) }}
{{ toTime(live.liveStartDate) }} - {{ toTime(live.liveEndDate) }}
{{ getNotification(live) }}
The ONCO Round table focuses on peer-to-peer discussions with high interactivity. Every panel member will be challenged to present his/her highlight from 2021 in five minutes. After a short Q&A, the panel will discuss various clinical dilemmas that physicians are confronted with in daily practice.
We invite you to join the discussion online!
Accreditation will be requested.
PROGRAMME
Scientific moderator: Prof. Dr. Eric Van Cutsem, UZ Leuven
| 19:30 - 20:25 | Highlights & discussion part 1 |
| Molecular analysis and treatment in bile duct cancer | |
| Prof. Dr. Anne Demols, ULB Erasme, Brussels | |
| Colorectal cancer | |
| Prof. Dr. Karen Geboes, UGent, Gent | |
| 20:25 | Break |
| 20:35 - 21:30 | Highlights & discussion part 2 |
| Unravelling the role of PDL testing | |
| Dr. Vasiliki Siozopoulou, UZA Antwerp | |
| lmmunotherapy in oesophagastric cancer | |
| Prof Dr. Marc Van Den Eynde, UCL Brussels | |
| 21:30 | Close |
Expert Panel
Prof. Dr. Eric Van Cutsem
Sienctific moderator, UZ Leuven
Prof. Dr. Anne Demols
ULB Erasme, Brussels
Prof. Dr. Karen Geboes
UGent, Gent
Dr. Vasiliki Siozopoulou
UZA Antwerp
Prof. Dr. Marc Van den Eynde
UCL Brussels
The ONCO Round table focuses on peer-to-peer discussions with high interactivity. Every panel member will be challenged to present his/her highlight from 2021 in five minutes. After a short Q&A, the panel will discuss various clinical dilemmas that physicians are confronted with in daily practice.
We invite you to join the discussion online!
Accreditation will be requested.
PROGRAMME
Scientific moderator: Prof. Dr. Eric Van Cutsem, UZ Leuven
| 19:30 - 20:25 | Highlights & discussion part 1 |
| Molecular analysis and treatment in bile duct cancer | |
| Prof. Dr. Anne Demols, ULB Erasme, Brussels | |
| Colorectal cancer | |
| Prof. Dr. Karen Geboes, UGent, Gent | |
| 20:25 | Break |
| 20:35 - 21:30 | Highlights & discussion part 2 |
| Unravelling the role of PDL testing | |
| Dr. Vasiliki Siozopoulou, UZA Antwerp | |
| lmmunotherapy in oesophagastric cancer | |
| Prof Dr. Marc Van Den Eynde, UCL Brussels | |
| 21:30 | Close |